Complications of Pregnancy 2 Flashcards

1
Q

what is chronic/essential hypertension in pregnancy?

A

This is HT that exists either pre-pregnancy or at booking (≤20 weeks gestation).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

hypertension in pregnancy: mild

A

diastolic 90-99

systolic 140-49

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

hypertension in pregnancy: moderate

A

diastolic 100-9

s 150-9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

hypertension in pregnancy: severe

A

d >=110

s >= 160

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what antihypertensive drugs can cause birth defects and impaired growth?

A

ramipril
enalopril
ARBs - lostartan, candestartan
diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what anti-hypertensive drugs are suitable during pregnancy?

A

labetolol
nifedipine
methyldopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is gestational hypertension?

A

Aka pregnancy induced hypertension (PIH). This is the classified in the same way as chronic but develops after 20 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is pre-eclampsia

A

New hypertension > 20 weeks in associate with significant proteinuria.
Definition:
Mild HT on two occasions more than 4 hours apart
or
Moderate to severe HT
+
Proteinuria of more than 300 mgms/24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

define significant proteinuria

A
  • Automated reagent strip urine protein estimation >1+
  • Spot urinary protein creatinine ratio >30mg/mmol
  • 24 hours urine protein collection >300mg/day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

pathophysiology of pre-eclampsia

A

It can be immunological or a genetic predisposition. Some theories include secondary invasion of maternal spiral arterioles by trophoblasts impaired resulting in reduced placental perfusion or an imbalance between vasodilators/vasoconstrictors in pregnancy. Prostacyclin/thromboxane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

risk factors for developing pre-eclampsia

A
• First pregnancy
• Extremes of maternal age
• Previous pre-eclampsia (esp. severe PET, delivery <34 weeks, IUGR baby, IUD, abruption)
• Pregnancy interval > 10 years
• BMI > 35
• Family history of PET
• Multiple pregnancy
• Underlying medical disorders
o Chronic hypertension
o Pre-existing renal disease
o Pre-existing diabetes
o Autoimmune disorders e.g. antiphospholipid antibodies, SLE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

pre-eclampsia: what organs does it affect?

A
kidneys
liver
vascular
cerebral
pulmonary
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pre-eclampsia: complications maternal

A
eclampsia
severe HT
HELLP
DIC
renal failure
pulmonary oedema, cardiac failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is HELLP syndrome?

A

haemolysis
elevated liver enzymes
low platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

pre-eclampsia: complications foetal

A

impaired placental perfusion:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

severe pre-eclampsia: symptoms/signs

A

o Headache, blurring of vision, epigastric pain, pain below ribs, vomiting, sudden
swelling of hands, face and legs
o Severe hypertension > 3+ proteinuria
o Clonus/brisk reflexes, papilledema, epigastric tenderness
o Reducing urine output
o Convulsions (eclampsia)

17
Q

severe pre-eclampsia: biochemical abnormalities

A

raised liver enzymes, bilirubin if HELLP present

raised urea and creatinine, raised urate

18
Q

severe pre-eclampsia: haematological abnormalities

A

low platelets
low haemoglobin, signs of haemolysis
features of DIC

19
Q

management of pre-eclampsia

A

• Frequent BP checks, urine protein
• Check symptomatology
o Headaches
o Epigastric pain
o Visual disturbances
• Check for hyper-reflexia (clonus), tenderness over the liber
• Blood investigations
o FBC (for haemolysis, platelets)
o LFTs
o U+Es
o Coagulation tests if indicated
• Foetal investigations
o Scan for growth
o CTG
• The only cure for PET is delivery of the baby and placenta
• Conservative (aim for foetal maturity)
o Close observation of clinical signs and investigations
o Anti-hypertensives (labetolol, methyldopa, nifedipine)
o Steroids for foetal lung maturity if gestation <36 weeks
• Consider induction of labour/CS if maternal or foetal condition deteriorates, irrespective of
gestation

20
Q

treatment of eclampsia

A

• Seizures can happen at any time – during pregnancy, labour
• Treatment of seizures/impending seizures
o Magnesium sulphate bolus + IV infusion
o Control of BP – IV labetolol, hydralazine if >160/110
o Avoid fluid overload – aim for 80mls/hr fluid intake

21
Q

prophylaxis for PET in subsequent pregnancy

A

low dose aspirin from 12 weeks till delivery

22
Q

what is gestational diabetes

A

b. Abnormal glucose tolerance that reverts to normal after delivery
c. However, more at risk of developing type II diabetes later in life

23
Q

discuss pre-existing diabetes and pregnancy

A

Insulin requirements of the mother increase as human placental lactogen, progesterone, human
chorionic gonadotrophin and cortisol from the placenta have anti-insulin actions. Foetal hyperinsulinemia
occurs as maternal glucose crosses the placenta and induces increased insulin production
in the foetus. The foetal hyperinsulinemia causes macrosomia. Post-delivery there is a greater risk of
neonatal hypoglycaemia.

24
Q

effects of diabetes on mother, foetus and neonate

A

• Increased risk of:
o Foetal congenital abnormalities (especially if blood sugars high peri-conception)
o Miscarriage
o Pre-eclampsia
o Foetal macrosomia, polyhydramnios
o Operative delivery, shoulder dystocia
o Worsening of maternal nephropathy, retinopathy, hypoglycaemia, reduced
awareness of hypoglycaemia
• Infections
• Stillbirth, increased perinatal mortality
• Neonatal
o Impaired lung maturity, neonatal hypoglycaemia, jaundice

25
Q

management of diabetes and pregnancy: preconception

A
o Better glycaemic control, ideally blood sugars should be around 4-7 mmol/l
preconception
o HbA1c < 6.5% (<48 mmol/mol)
o Folic acid 5mg
o Dietary advice
o Retinal and renal assessment
26
Q

management of diabetes and pregnancy: during pregnancy

A

o Optimise glucose control – insulin requirements will increase
§ <5.3 mmol/l fasting
§ <7.8 mmol/l 1 hour postprandial
§ <6.4 mmol/l 2 hours postprandial
§ <6 mmol/l before bedtime
o Could continue oral anti-diabetic agents (metformin) but may need to change to
insulin for tighter glucose control
o Should be aware of the risk of hypoglycaemia – provide glucagon injections/conc.
Glucose solution
o Watch for ketonuria/infections
o Repeat retinal assessments 28 and 34 weeks
o Watch foetal growth

27
Q

management of diabetes and pregnancy: labour

A
  • Observe for PET
  • Labour usually induced 38-40 weeks, earlier if foetal or maternal concerns
  • Consider elective C-section if significant foetal macrosomia
  • Maintain blood sugar in labour with insulin – dextrose insulin infusion
  • Continuous CTG foetal monitoring in labour
  • Early feeding of baby to reduce neonatal hypoglycaemia
  • Can go back to pregnancy regimen of insulin post delivery
28
Q

risk factors for gestational diabetes

A

• Increased BMI >30
• Previous macrosomic baby > 4.5 kg
• Previous GDM
• Family history of diabetes
• Women from high risk groups for developing diabetes e.g. Asian origin
• Polyhydramnios or big baby in current pregnancy
• Recurrent glycosuria in current pregnancy
GDM associated with some increase in maternal complications (e.g. PET) and foetal complications (macrosomia) but much less than with type I or II diabetes.

29
Q

screening for gestational diabetes

A

If risk factors present offer HbA1C estimation at booking, if >6% (43 mmol/mol), 75gms OGTT to be done. If OGTT normal, repeat OGTT at 24-28 weeks. Can also offer OGTT at around 16 weeks and repeat at 28 weeks if significant risk factors (e.g. previous GDM present).

30
Q

management of gestational diabetes

A

• Control of blood sugars
o Diet
o Metformin/insulin if sugars remain high
• Post-delivery check OGTT 608 weeks PN
• Yearly check on HbA1C/blood sugars as at a higher risk of developing overt diabetes

31
Q

why are pregnant women more at risk of VTE?

A

Pregnancy is a hypercoagulable state to protect the mother against bleeding post-delivery. However, this puts women at a greater risk of VTE. There is an increase in fibrinogen, factor VIII, VW factor and platelets. Decrease in natural anticoagulants such as antithrombin III. Finally, there is an increase in fibrinolysis.

32
Q

risk factors for VTE in pregnancy

A
  • Older mothers, increasing parity
  • Increased BMI, smokers
  • IVDU
  • PET
  • Dehydration – hyperemesis
  • Decreased mobility
  • Infections
  • Operative delivery, prolonged labour
  • Haemorrhage, blood loss > 2l
  • Previous VTE (not explained by other predisposing injuries e.g. fractures), those with thrombophilia (protein C, protein S, anti-thrombin III deficiencies etc), strong family Hx of VTE
  • Sickle cell disease
33
Q

VTE in pregnancy prophylaxis and treatment

A

• TED stockings
• Advise increased mobility
• Prophylactic anti-coagulation with 3 or more risk factors (may be indicated even with one risk
factor if significant risk), may need to continue 6 weeks postpartum
o Dalteparin
Appropriate treatment with anticoagulation if VTE confirmed

34
Q

signs and symptoms of VTE in pregnancy

A
o Pain in calf
o Breathlessness
o Pain on breathing
o Cough
o Tachycardia
o Hypoxic
o Increased girth of affected leg
o Calf muscle tenderness
o Pleural rub
35
Q

investigations of VTE in pregnancy

A
o ECG
o BG
o Doppler
o V/Q lung scan
o CTPA